09.14.2023 - By ReachMD
Guest: Sami Khella, MD
While there are FDA-approved treatments for CIDP, patients remain, to a large extent, fairly disabled by this illness. However, there are several ways in which clinicians can work with their patients to provide the best care possible. Dive in with Dr. Sami Khella, Professor of Clinical Neurology at Penn Medicine University City in Philadelphia.